The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis
about
Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysisAtypical antipsychotics for psychosis in adolescentsEarly intervention for psychosisAntipsychotic medication for early episode schizophreniaEarly Intervention for psychosisComparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study.Prediction and prevention of schizophrenia: what has been achieved and where to go next?Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adultsEarly signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disordersNeurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective.Prospective investigations of the prodromal state of schizophrenia: review of studies.Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psNeurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker.First-episode psychosis, early intervention, and outcome: what have we learned?Prevention of schizophrenia.Antipsychotic interventions in prodromal psychosis: safety issues.Psychotherapy for adolescents and young adults at high risk for psychosis: a systematic review.Development of a group and family-based cognitive behavioural therapy program for youth at risk for psychosis.Can clinicians predict psychosis in an ultra high risk group?Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.Longitudinal study examining abnormal white matter integrity using a tract-specific analysis in individuals with a high risk for psychosis.The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum.Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia.Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic studyThe Concept of Schizophrenia: From Unity to Diversity
P2860
Q22251382-9C7F901A-98E0-44F8-970F-7A137CF9AE12Q24197475-3E59F592-2335-4376-B820-F8DBECCB74B1Q24236296-890992FF-B3EE-4962-AAF1-AAD3F8D7D6D7Q24236683-D5918E41-7C78-474E-9A4B-D6E8482A9943Q24243986-7F1A5B52-3F5A-455D-AA54-BBC06E57CC90Q30400031-FC2054B1-950E-4482-8EB3-3810904369CDQ30473765-C8C11357-9B29-4849-B5A3-F681AFCE074BQ30493124-EEA23110-B8D2-47B5-8849-BDA52C6D8B91Q34095720-4D4FB257-3E74-4695-9E00-566C0779288EQ34322929-A4B08F2A-7148-4601-8A40-5658003B1B7CQ34566772-5A9DD193-EEF5-4D18-9D2E-522A83B3268BQ35176725-4B4B7C2A-D762-4D7F-BDE9-031A7571EE43Q35829532-A367BA37-F1ED-46FF-9A40-48C2D2355CFDQ36403643-FDC81850-1082-45A9-A9D4-6D8BA1E56FD0Q37768447-EC9090B3-767D-44DB-A152-60AA64E0B698Q38084211-C8490A79-060B-41EC-8796-0E92C02CCB9CQ38191698-6D750347-9B59-46F9-95BA-9AEFDCE1FCA8Q39273121-08C153F7-D331-4B60-BD05-853A6CD24EB9Q39882342-47F1D011-9392-45FC-89B3-E18D5C45FC1DQ43294340-CA304A56-AA46-4565-9C26-54C67543F030Q47794794-4FE88863-D0D5-4195-A4FA-08A94987A790Q47945243-219453A7-FD94-48F0-9440-EA2A4E7B1C78Q48393097-1E9AD98E-C05E-4D2B-9A7C-2BC310E97250Q57519639-09AD1797-B11D-4295-86D4-0F1F99D44794Q59052397-6635B666-644D-4890-9731-5F865443FE44
P2860
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The PRIME North America random ...... ally symptomatic for psychosis
@ast
The PRIME North America random ...... ally symptomatic for psychosis
@en
type
label
The PRIME North America random ...... ally symptomatic for psychosis
@ast
The PRIME North America random ...... ally symptomatic for psychosis
@en
prefLabel
The PRIME North America random ...... ally symptomatic for psychosis
@ast
The PRIME North America random ...... ally symptomatic for psychosis
@en
P2093
P1476
The PRIME North America random ...... ally symptomatic for psychosis
@en
P2093
J Addington
K.A Hawkins
R.B Zipursky
S Lindborg
T.J Miller
P356
10.1016/S0920-9964(02)00439-5
P407
P577
2003-05-01T00:00:00Z